The Molecular Basis of Cisplatin Resistance in Bladder Cancer Cells

QR Code

The Molecular Basis of Cisplatin Resistance in Bladder Cancer Cells

None

Saved in:

Bibliographic Details
Main Authors:	Köberle, Beate, Piee-Staffa, Andrea
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27326
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Detection of Cisplatin Resistance in Bladder Cancer Using Machine Learning
by: Moditha Reddy Jagannatha Reddy, et al.
Published: (2025-01-01)

Cisplatin Resistance in Malignant Pleural Mesothelioma
by: Behnam-Motlagh, Parviz, et al.
Published: (2012)

The Molecular Basis of Resistance to the Antiproliferative Effect of EGFR Inhibition in Human Glioblastoma Multiforme Cell Lines
by: Karpel-Massler, Georg, et al.
Published: (2011)

Connexin 43 Enhances the Cisplatin-Induced Cytotoxicity in Mesothelioma Cells
by: Sato, Hiromi, et al.
Published: (2012)

UHRF1 is a Potential Molecular Marker for Diagnosis and Prognosis of Bladder Cancer
by: Unoki, Motoko
Published: (2012)

Schistosomasis and Bladder Cancer
by: Eissa, Saad S., et al.
Published: (2012)

Bladder Cancer Biology
by: Fuessel, Susanne, et al.
Published: (2012)

Molecular Basis of Thalassemia
by: Grosso, Michela, et al.
Published: (2012)

Epigenetic Biomarkers in Bladder Cancer
by: Zimbardi, Daniela, et al.
Published: (2012)

Angiogenesis and Lymphangiogenesis in Bladder Cancer
by: Miyata, Yasuyoshi, et al.
Published: (2012)

Hemocyanins in the Immunotherapy of Superficial Bladder Cancer
by: Arancibia, Sergio, et al.
Published: (2012)

Migraine: Molecular Basis and Herbal Medicine
by: Ansari, Mohammad, et al.
Published: (2012)

Bladder Cancer and Schistosomiasis: Is There a Difference for the Association?
by: Zaghloul, Mohamed S., et al.
Published: (2012)

Cell Cycle Regulatory Proteins in Breast Cancer: Molecular Determinants of Drug Resistance and Targets for Anticancer Therapies
by: Ahmad, Aamir, et al.
Published: (2012)

Animal Models for Basic and Preclinical Research in Bladder Cancer
by: Eiján, Ana María, et al.
Published: (2012)

Epidemiology and Polymorphisms Related to Bladder Cancer in Ecuadorian Individuals
by: Paz-y-Miño, César, et al.
Published: (2012)

Molecular Traits of the Budding Colorectal Cancer Cells
by: Nielsen, Boye Schnack
Published: (2012)

Neuroblastoma – Molecular Basis for Diagnosis and Staging System
by: Babié, Priscila Torres, et al.
Published: (2012)

Molecular Mechanisms Involving Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma (HNSCC) – Roles of Hypoxic Microenvironment and Cancer Stem Cell
by: Li, Xiaoming, et al.
Published: (2012)

Transcriptome profiling of cervical cancer cells acquired resistance to cisplatin by deep sequencing
by: Yamin Wang, et al.
Published: (2019-12-01)

Chemoprevention and Novel Treatments of Non-Muscle Invasive Bladder Cancer
by: Luchey, Adam, et al.
Published: (2012)

Angiogenesis, Lymphangiogenesis and Lymphovascular Invasion: Prognostic Impact for Bladder Cancer Patients
by: Afonso, Julieta, et al.
Published: (2012)

IBMPFD and p97, the Structural and Molecular Basis for Functional Disruption
by: Tang, Wai-Kwan, et al.
Published: (2012)

VPA does not enhance platinum binding to DNA in cisplatin-resistant neuroblastoma cancer cells
by: Martina Raudenska, et al.
Published: (2017-09-01)

Human Embryonic Stem Cells: A Model System for Delineating the Molecular Basis of Human Embryogenesis and Aging-related Diseases
by: Atwood, Craig S., et al.
Published: (2011)

Prospective Study of Triple Combination Chemotherapy Consisting of Paclitaxel, S-1, and 24-Hour Infusion of Cisplatin (PSC) for Inoperable Highly Advanced Gastric Cancer
by: Ina, Kenji, et al.
Published: (2011)

Diagnosis and Treatment of Overactive Bladder
by: Shaw, Howard A., et al.
Published: (2012)

Biomarkers in the Overactive Bladder Syndrome
by: Cruz, Célia Duarte, et al.
Published: (2012)

Prevention of Bladder Tumor Recurrence
by: Amos, Shapiro, et al.
Published: (2012)

The H19-IGF2 Role in Bladder Cancer Biology and DNA-Based Therapy
by: Matouk, Imad, et al.
Published: (2012)

Biomarkers of Bladder Cancer in Urine: Evaluation of Diagnostic and Prognostic Significance of Current and Potential Markers
by: Dawam, Daben
Published: (2012)

Molecular genetic subtypes of bladder cancer
by: S. V. Kotov, et al.
Published: (2023-10-01)

Modulation of Multidrug Resistance on the Same Single Cancer Cell in a Microfluidic Chip: Intended for Cancer Stem Cell Research
by: Li, XiuJun, et al.
Published: (2011)

Molecular Epidemiology and Drug Resistance of Tuberculous Meningitis
by: Faksri, Kiatichai, et al.
Published: (2012)

Multidrug Resistance Transporters – Roles in maintaining Cancer Stem-Like Cells
by: To, et al.
Published: (2011)

Robot-Assisted Radical Cystectomy as a Treatment Modality for Patients with Muscle-Invasive Bladder Cancer
by: Schumacher, Martin C.
Published: (2012)

Adipokines – Toward the Molecular Dissection of Interactions Between Stromal Adipocytes and Breast Cancer Cells
by: Fan, Pengcheng, et al.
Published: (2011)

Molecular Biology of Thyroid Cancer
by: Viglietto, Giuseppe, et al.
Published: (2011)

INVESTIGATION OF THE EFFECTS OF JUGLONE AND CISPLATIN ON BREAST CANCER CELL LINES
by: Selda Şimşek, et al.
Published: (2025-06-01)

Th1 Cytokine-Secreting Recombinant Bacillus Calmette-Guérin: Prospective Use in Immunotherapy of Bladder Cancer
by: Luo, Yi, et al.
Published: (2011)